Skip to main content

Table 2 Event rates of the composite endpoints

From: Differing effects of beta-blockers on long-term clinical outcomes following percutaneous coronary intervention between patients with mid-range and reduced left ventricular ejection fraction

  mrEF rEF
β-blocker ( +) (n = 163) β-blocker ( −) (n = 153) β-blocker ( +) (n = 99) β-blocker ( −) (n = 102)
All-cause death, n (%) 30 (18.4) 30 (19.6) 25 (25.3) 52 (51.0)
Non-fatal ACS, n (%) 13 (8.0) 23 (15.0) 6 (6.1) 9 (8.8)
  1. ACS acute coronary syndrome, mrEF mid-range ejection fraction, rEF reduced ejection fraction